Search results for: “keytruda”
-
Blog
Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy
A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.
-
Blog
The History and Future of Cancer Immunotherapy
The path to achieving immunotherapy’s full potential.
-
Blog
FDA Regulatory Definitions
You heard that a drug in clinical trials was Fast Tracked. Or you heard that a treatment…
-
Blog
Immunotherapy Approvals in 2015
In 2015, the FDA approved more immunotherapies than in any prior year.
-
Blog
Top 5 Cancer Immunotherapy Stories of 2015
Here’s what you, our online community, thought were the biggest stories of 2015.
-
Blog
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer
New hope now exists for patients with advanced kidney cancer.
-
Blog
FDA Approves Expanded Use of Nivolumab for Lung Cancer
Nivolumab, a PD-1 immunotherapy, is now approved as second-line therapy for the most common type of lung…
-
Blog
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer
Patients with non-small cell lung cancer may now receive a PD-1 immunotherapy as second-line treatment after chemotherapy.
-
Blog
CICON15 Report from Day 1
Highlights from Day 1 of the inaugural International Cancer Immunotherapy Conference.